Drug controller allows Indian firm to conduct phase 1 trials for Zika vaccine
Indian Express By: Express News Service New Delhi: December 19, 2017 Zika is an infection spread by the Aedes egypti mosquito. Infections in pregnant women can cause children to be born with brain deficiencies The Drugs Controller General of India has granted permission to an Indian firm to conduct Phase-I clinical trials for a Zika vaccine. Zika is an infection spread by the Aedes egypti mosquito. Infections in pregnant women can cause children to be born with brain deficiencies. Union Minister of State for Health and Family Welfare Ashwini Kumar Choubey told the Lok Sabha on Monday that an Indian firm had submitted an application to the drugs controller. “The application was on the Zika virus vaccine, along with non-clinical (animal) toxicity data, claiming 100 per cent efficacy in animals for grant of permission to conduct the Phase-I clinical trial. Based on the evaluation of application, in consultation with the Experts Committee, the DCG (I) has grant...